Nurix Therapeutics: The Prospects Of A ‘New Class’ Of Cancer Drug (NASDAQ:NRIX)


Goal achievement. Ambition aiming growth to success. Dartboard and arrow on light blue background. 3d rendering illustration

marchmeena29/iStock via Getty Images

Topline Summary

Nurix Therapeutics (NASDAQ:NRIX) is a biotech company specializing in the development of protein degraders, which are intended as a new class of cancer therapeutic exploiting known targets, some of which have currently approved targeted



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *